These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24784346)

  • 1. Wilms' tumor gene 1 immunotherapy in pelvic gynecological malignancies.
    Coosemans A; Vergote I; Van Gool SW
    Expert Rev Clin Immunol; 2014 Jun; 10(6):705-11. PubMed ID: 24784346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor 1 (WT1) peptide immunotherapy for gynecological malignancy.
    Ohno S; Kyo S; Myojo S; Dohi S; Ishizaki J; Miyamoto K; Morita S; Sakamoto J; Enomoto T; Kimura T; Oka Y; Tsuboi A; Sugiyama H; Inoue M
    Anticancer Res; 2009 Nov; 29(11):4779-84. PubMed ID: 20032435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
    Sugiyama H
    Expert Rev Vaccines; 2005 Aug; 4(4):503-12. PubMed ID: 16117707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.
    Sugiyama H
    Jpn J Clin Oncol; 2010 May; 40(5):377-87. PubMed ID: 20395243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [WT1-targeting cancer vaccine].
    Sugiyama H
    Nihon Rinsho; 2012 Dec; 70(12):2105-13. PubMed ID: 23259381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms' Tumor Gene 1 (WT1)--loaded dendritic cell immunotherapy in patients with uterine tumors: a phase I/II clinical trial.
    Coosemans A; Vanderstraeten A; Tuyaerts S; Verschuere T; Moerman P; Berneman ZN; Vergote I; Amant F; VAN Gool SW
    Anticancer Res; 2013 Dec; 33(12):5495-500. PubMed ID: 24324087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of myeloid dendritic cells can predict the efficacy of Wilms' tumor 1 peptide vaccination.
    Ohno S; Takano F; Ohta Y; Kyo S; Myojo S; Dohi S; Sugiyama H; Ohta T; Inoue M
    Anticancer Res; 2011 Jul; 31(7):2447-52. PubMed ID: 21873158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunotherapy targeting WT1 protein.
    Sugiyama H
    Int J Hematol; 2002 Aug; 76(2):127-32. PubMed ID: 12215010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer.
    Koido S; Okamoto M; Shimodaira S; Sugiyama H
    Immunotherapy; 2016 Nov; 8(11):1309-1320. PubMed ID: 27993090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system.
    Kanda T; Ochi T; Fujiwara H; Yasukawa M; Okamoto S; Mineno J; Kuzushima K; Tsurumi T
    Cancer Gene Ther; 2012 Aug; 19(8):566-71. PubMed ID: 22722376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.
    Van Driessche A; Berneman ZN; Van Tendeloo VF
    Oncologist; 2012; 17(2):250-9. PubMed ID: 22291091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wilms' tumor 1 (WT1) as a prognosis factor in gynecological cancers: A meta-analysis.
    Lu J; Gu Y; Li Q; Zhong H; Wang X; Zheng Z; Hu W; Wen L
    Medicine (Baltimore); 2018 Jul; 97(28):e11485. PubMed ID: 29995811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Heme Oxygenase-1 Activity Enhances Wilms Tumor-1-Specific T-Cell Responses in Cancer Immunotherapy.
    Schillingmann DA; Riese SB; Vijayan V; Tischer-Zimmermann S; Schmetzer H; Maecker-Kolhoff B; Blasczyk R; Immenschuh S; Eiz-Vesper B
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 peptide-based immunotherapy for patients with lung cancer: report of two cases.
    Tsuboi A; Oka Y; Osaki T; Kumagai T; Tachibana I; Hayashi S; Murakami M; Nakajima H; Elisseeva OA; Fei W; Masuda T; Yasukawa M; Oji Y; Kawakami M; Hosen N; Ikegame K; Yoshihara S; Udaka K; Nakatsuka S; Aozasa K; Kawase I; Sugiyama H
    Microbiol Immunol; 2004; 48(3):175-84. PubMed ID: 15031530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma.
    Coosemans A; Vanderstraeten A; Tuyaerts S; Verschuere T; Moerman P; Berneman Z; Vergote I; Amant F; Van Gool SW
    Anticancer Res; 2013 Sep; 33(9):3855-9. PubMed ID: 24023319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic targeting of Wilms' tumor protein.
    Hutchings Y; Osada T; Woo CY; Clay TM; Lyerly HK; Morse MA
    Curr Opin Mol Ther; 2007 Feb; 9(1):62-9. PubMed ID: 17330403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma.
    Coosemans A; Wölfl M; Berneman ZN; Van Tendeloo V; Vergote I; Amant F; Van Gool SW
    Anticancer Res; 2010 Sep; 30(9):3709-14. PubMed ID: 20944158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope.
    Li Z; Oka Y; Tsuboi A; Fujiki F; Harada Y; Nakajima H; Masuda T; Fukuda Y; Kawakatsu M; Morimoto S; Katagiri T; Tatsumi N; Hosen N; Shirakata T; Nishida S; Kawakami Y; Udaka K; Kawase I; Oji Y; Sugiyama H
    Microbiol Immunol; 2008 Nov; 52(11):551-8. PubMed ID: 19090835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.